Previous Page  40 / 64 Next Page
Information
Show Menu
Previous Page 40 / 64 Next Page
Page Background

DART study: Dalantercept plus Axitinib. Fase I

Activin receptor-like kinase 1

Voss MH. Clin Cancer Res. 2017 Jul 15;23(14):3557–65.

1 … 35 36 37 38 39 40 41 42 43 44 45 46 … 64  FlippingBook